Patent · US Active

Pharmaceutical compounds

US9145354B2 · kind B2 · utility

0Cited by
8References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2012
Grant dateSep 29, 2015
Priority date
Expiry dateOct 31, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compounds that are useful in the treatment of hepatitis C virus (HCV) infections. The compounds have the formula (1):or a salt, N-oxide, tautomer or stereoisomer thereof, wherein A is CH or N; E is CH or N;

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.